Influential Russian takes a big stake in U.S. biotechs

Anatoly Chubais is one of the most influential figures in the Russian government. And he's now using his influence to invest billions of dollars in new technology through Rusnano, a move that has benefited a slate of U.S. biotechs, including Bind Biosciences and Selecta Biosciences, which are opening laboratories near Moscow. Bloomberg profiles Chubais and his plans for future investments. Story